Expression of wild-type and noncleavable Fas ligand by tetracycline-regulated adenoviral vectors to limit intimal hyperplasia in vascular lesions

被引:23
作者
Mano, T [1 ]
Luo, ZY [1 ]
Suhara, T [1 ]
Smith, RC [1 ]
Esser, S [1 ]
Walsh, K [1 ]
机构
[1] Tufts Univ, St Elizabeths Med Ctr, Sch Med, Div Cardiovasc Res, Boston, MA 02135 USA
关键词
D O I
10.1089/10430340050111287
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Proliferation of vascular smooth muscle cells (VSMCs) and the infiltration of T cells and macrophages into vessel wall are considered to be important for intimal lesion formation after balloon angioplasty. Previous studies have shown that Fas ligand (FasL) gene transfer to balloon-injured vessels inhibits lesion formation by killing both proliferating VSMCs and infiltrating inflammatory cells. Here, we describe the construction and utility of a binary, tetracycline-regulated adenovirus system that pro,ides controlled transgene expression in vitro and in vivo. In this system, optimal transgene expression required cotransfection with an adenovirus encoding the tetracycline-dependent trans-activator (rtTA) and induction with doxycycline hydrochloride (DOX), an analog of tetracycline. Using this system, adenovirus constructs were designed that allow regulated expression of wild-type Fast and a noncleavable mutant of Fast (Fast-NC). Transduction of Fast and Fast-NC induced similar extents of apoptosis in proliferating VSMCs in vitro in a manner that was dependent on the doses of the rtTA adenovirus and the presence of DOX in the medium. Furthermore, inhibition of intimal hyperplasia in injured carotid arteries by Fast or Fast-NC transduction was also dependent on cotransfection with the rtTA adenovirus and administration of DOX by subcutaneous injection. In contrast to wild-type Fast, transduction of Fast-NC did not result in the production of soluble (cleaved) Fast in the medium of infected cells lit vitro, or in the serum of rats after local gene transfer to carotid arteries, In conclusion, this binary tetracycline-inducible adenovirus system may allow for safer delivery of cytotoxic genes for therapeutic purposes.
引用
收藏
页码:1625 / 1635
页数:11
相关论文
共 51 条
[1]   Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand [J].
Ambar, BB ;
Frei, K ;
Malipiero, U ;
Morelli, AE ;
Castro, MG ;
Lowenstein, PR ;
Fontana, A .
HUMAN GENE THERAPY, 1999, 10 (10) :1641-1648
[2]  
ARAI H, 1997, P NATL ACAD SCI USA, V94, P13682
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[5]   A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors [J].
Corti, O ;
Sabaté, O ;
Horellou, P ;
Colin, P ;
Dumas, S ;
Buchet, D ;
Buc-Caron, MH ;
Mallet, J .
NATURE BIOTECHNOLOGY, 1999, 17 (04) :349-354
[6]   Levels of soluble FasL and FasL gene expression during the development of graft-versus-host disease in DLT-treated patients [J].
Das, H ;
Imoto, S ;
Murayama, T ;
Kajimoto, K ;
Sugimoto, T ;
Isobe, T ;
Nakagawa, T ;
Nishimura, R ;
Koizumi, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) :795-800
[7]   SMALL STENT SIZE AND INTIMAL HYPERPLASIA CONTRIBUTE TO RESTENOSIS - A VOLUMETRIC INTRAVASCULAR ULTRASOUND ANALYSIS [J].
DUSSAILLANT, GR ;
MINTZ, GS ;
PICHARD, AD ;
KENT, KM ;
SATLER, LF ;
POPMA, JJ ;
WONG, SC ;
LEON, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (03) :720-724
[8]   Highly controlled gene expression using combinations of a tissue-specific promoter recombinant adenovirus and a tetracycline-regulatable transcription factor [J].
Ghersa, P ;
Gobert, RP ;
Sattonnet-Roche, P ;
Richards, CA ;
Pich, EM ;
van Huijsduijnen, RH .
GENE THERAPY, 1998, 5 (09) :1213-1220
[9]   TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS [J].
GOSSEN, M ;
BUJARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5547-5551
[10]   TRANSCRIPTIONAL ACTIVATION BY TETRACYCLINES IN MAMMALIAN-CELLS [J].
GOSSEN, M ;
FREUNDLIEB, S ;
BENDER, G ;
MULLER, G ;
HILLEN, W ;
BUJARD, H .
SCIENCE, 1995, 268 (5218) :1766-1769